Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated ...

NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...

NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a $2.14 billion market cap biotechnology company currently trading near its 52-week low of $16.57 ... aimed at treating IgA nephropathy (IgAN ...

After treatment, the serum IgA and IgG levels in the model group were 1.12 ± 0.37 ... Triple costimulation via CD80, 4-1BB, and CD83 ligand elicits the long-term growth of Vγ9Vδ2 T cells in low levels ...

Measurement of serum immunity indexes: Serum immunity kits were used to determine the serum levels of immunoglobulin A (IgA), immunoglobulin M (IgM), and ... vortex mixing for 30 s, low temperature ...

FBS, ALT, serum creatinine, and lipid profile (total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol ... has been the most reported GN so far ...

Iga Swiatek’s Indian Wells crash-out has resulted in an unfortunate low for her. The Pole now holds no titles outside clay, having endured some forgettable results lately. Swiatek, the second ...

Swiatek addressed what happened last week at the tournament in Indian Wells, California, where she smacked a ball and it ...